These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Changes in oxygen saturation of the blood due to fominoben in chronic lesions of the respiratory tract with special reference to silicosis]. Köhler ER Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:351-3. PubMed ID: 4740112 [No Abstract] [Full Text] [Related]
6. [Exoperiences with fominoben in relation to the antitussive effect in the professional pneumology practice]. Göbel P; Göbel-Rieken E Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:366-8. PubMed ID: 4740119 [No Abstract] [Full Text] [Related]
7. [Therapeutic effect of fominoben in obstructive respiratory disorders and respiratory insufficiency]. Uhl O Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:338-4. PubMed ID: 4575175 [No Abstract] [Full Text] [Related]
8. [Fominoben and respiratory function]. Schindl R Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:342-7. PubMed ID: 4740110 [No Abstract] [Full Text] [Related]
9. [Respiratory function tests using fominoben]. Grabow L Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:357-9. PubMed ID: 4740115 [No Abstract] [Full Text] [Related]
10. [Results of animal experiments and clinical testing with Noleptan]. Renovanz HD Fortschr Med; 1973 Sep; 91(25):1003-8. PubMed ID: 4585192 [No Abstract] [Full Text] [Related]
11. [Fominoben, a new respiratory drug]. Wieser O; Witzel K Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:337-8. PubMed ID: 4740109 [No Abstract] [Full Text] [Related]
12. [Therapy of bronchitis using fominoben in general practice]. Kessler H Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:368-9. PubMed ID: 4740120 [No Abstract] [Full Text] [Related]
13. [Clinical observations during long-term therapy with fominoben]. Arch F Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:363-6. PubMed ID: 4740118 [No Abstract] [Full Text] [Related]
14. [Pharmacological studies on a substance with antitussive and respiration stimulating properties]. Püschmann S; Engelhorn R Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:296-3. PubMed ID: 4145312 [No Abstract] [Full Text] [Related]
15. [Antitussive therapy of chronic unspecific bronchial and lung diseases. Double blind study]. Loos M Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:331-6. PubMed ID: 4575174 [No Abstract] [Full Text] [Related]
16. [Long-term therapy with the respiratory agent fominoben]. Gerhard K Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:361-3. PubMed ID: 4740117 [No Abstract] [Full Text] [Related]
17. [Fominoben and central respiratory control]. Nolte D; Streller SE Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:348-5. PubMed ID: 4740111 [No Abstract] [Full Text] [Related]
18. [Influence of 3'-chloro-2'-((methyl((morpholino-carbonyl)-methyl)amino)methyl)benzanilide-hydrochloride (PB 89) on respiration]. Schindl R Wien Med Wochenschr; 1972 May; 122(19):280-1. PubMed ID: 5048583 [No Abstract] [Full Text] [Related]
19. Pharmacokinetics and metabolism of fominoben (Noleptan) in man. Zimmer A Arzneimittelforschung; 1973 Dec; 23(12):1798-1801. PubMed ID: 4150215 [No Abstract] [Full Text] [Related]